Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of diCELLa and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
diCELLa is a technology company based in Krakow, Poland, that provides specialized software solutions for the clinical research industry. The company focuses on digitizing and streamlining clinical trial workflows through platforms including eCRF (electronic Case Report Form), CTMS (Clinical Trial Management System), IWRS (Interactive Web Response System), and eTMF (electronic Trial Master File). Beyond its core clinical trial software, diCELLa leverages artificial intelligence and machine learning to offer advanced tools for medical image analysis, particularly in microscopy. The company emphasizes regulatory compliance, adhering to standards such as ISO 9001 and ISO 27001, as well as US FDA 21 CFR Part 11 and HIPAA requirements, to ensure data integrity and security in clinical studies.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:CRO
Sub-Industry:Clinical Trial Software / HealthTech
SIZE & FINANCIALS
Employees:1-50
Founded:2017
Ownership:private
Status:operating
0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Aleksandra Kubica-Misztal - COO / Founder
Krzysztof Misztal - R&D Team Leader / Founder
Scientific Founders:Aleksandra Kubica-Misztal, Krzysztof Misztal
LINKS
Website:dicella.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with diCELLa. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.